Insights

Bayvrio has added an unbranded biosimilar to Humira® (adalimumab) to the Bayvrio Marketplace, available to any hospital or licensed specialty […]

Pharmacy is at a turning point. For decades, healthcare payers have been locked into rigid, bundled contracts that lack transparency

Clinically interchangeable drug will be available to any licensed specialty pharmacy in the U.S. through Bayvrio Marketplace supplier, Birdi, Inc.

Payers can choose from best-in-class solutions and suppliers to build, manage, and deliver pharmacy benefit and healthcare strategies tailored to

Strategic investment will radically change how payers manage benefits, costs, and care SAN DIEGO, CA AND TAMPA, FL – MedImpact Holdings’